📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Kallyope

1.1 - Company Overview

Kallyope Logo

Kallyope

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medicines developed using the science of gut-brain biology to transform human health.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Kallyope

4D Pharma Logo

4D Pharma

HQ: United Kingdom Website
  • Description: Provider of live biotherapeutics, a novel class of drugs defined by the FDA as biological products containing a live organism, such as bacteria, applicable to the prevention, treatment or cure of disease; developer of MicroRx, a proprietary platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 4D Pharma company profile →
MicuRx Pharmaceuticals Logo

MicuRx Pharmaceuticals

HQ: United States Website
  • Description: Provider of novel antimicrobials for drug-resistant infections. Portfolio includes Contezolid (MRX-I), an oxazolidinone for complicated skin and soft tissue infections (targets MRSA, VRE); Contezolid acefosamil (MRX-4), an injectable oxazolidinone in Phase III; MRX-8, a polymyxin for multidrug-resistant Gram-negative; MRX-5, a boron compound; MRX-7, a pleuromutilin inhibitor; and MRX-15, a kidney-targeted therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MicuRx Pharmaceuticals company profile →
Adaptive Phage Therapeutics Logo

Adaptive Phage Therapeutics

HQ: United States Website
  • Description: Provider of phage-based therapeutic services for multi-drug resistant pathogenic bacteria, using clinical technology to match phages to patient-specific infections; offerings include BX004 for cystic fibrosis Pseudomonas aeruginosa, BX211 for diabetic foot osteomyelitis, personalized and optimized phage therapies, and the XMarker platform for microbial biomarker discovery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adaptive Phage Therapeutics company profile →
Solarea Bio Logo

Solarea Bio

HQ: United States Website
  • Description: Provider of microbial therapeutics and microbial-based solutions targeting chronic inflammation. Develops Defined Microbial Assemblage products combining probiotic microbes from fruits and vegetables with prebiotic fibers, advances medical foods, and creates synbiotics to protect against bone loss. Also offers licensing of its microbial-based technology, including a technology licensing agreement with ADM.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Solarea Bio company profile →
BioCare Copenhagen Logo

BioCare Copenhagen

HQ: Denmark Website
  • Description: Provider of dietary supplements with microbial components for gastrointestinal problems, infections, and immune enhancement; offers medical nutrition, early life nutrition, pharma solutions, and nutrition improvement. Products include Humiome B2, supporting gut health by delivering a high percentage of vitamin B2 to the colon.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioCare Copenhagen company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Kallyope

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Kallyope

2.2 - Growth funds investing in similar companies to Kallyope

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Kallyope

4.2 - Public trading comparable groups for Kallyope

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Kallyope

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Kallyope

What does Kallyope do?

Kallyope is a provider of medicines developed using the science of gut-brain biology to transform human health.

Who are Kallyope's competitors?

Kallyope's competitors and similar companies include 4D Pharma, MicuRx Pharmaceuticals, Adaptive Phage Therapeutics, Solarea Bio, and BioCare Copenhagen.

Where is Kallyope headquartered?

Kallyope is headquartered in United States.

How many employees does Kallyope have?

Kallyope has 1,000 employees 🔒.

When was Kallyope founded?

Kallyope was founded in 2010 🔒.

What sector and industry vertical is Kallyope in?

Kallyope is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Kallyope

Who are the top strategic acquirers in Kallyope's sector and industry

Top strategic M&A buyers and acquirers in Kallyope's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Kallyope?

Top strategic M&A buyers groups and sectors for Kallyope include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Kallyope's sector and industry vertical

Which are the top PE firms investing in Kallyope's sector and industry vertical?

Top PE firms investing in Kallyope's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Kallyope's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Kallyope's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Kallyope's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Kallyope include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Kallyope's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Kallyope?

The key public trading comparables and valuation benchmarks for Kallyope include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Kallyope for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Kallyope with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Kallyope's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Kallyope with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Kallyope's' sector and industry vertical?

Access recent funding rounds and capital raises in Kallyope's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Kallyope